Pharmacology in special populations: extreme age
https://doi.org/10.24411/2588-0519-2019-10074
Abstract
The article deals the definition, history of development in Russia, the main provisions, problems and prospects of development of pharmacology of extreme ages. The features of the nomenclature of medicines and the applicability of different dosage forms in different age periods are shown. Recommendations on rational use of medicines in patients of special populations — extreme ages are given. The risks of responsible self-treatment and polypharmacology are indicated. The data of international monitoring of drug safety in patients of extreme ages are presented. The article is addressed to pharmacologists, clinical pharmacologists, drug developers and doctors of medical specialties.
About the Authors
B. K. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Romanov Boris - MD, Assoc. Prof., Deputy General Director for Science Research.
Moscow
SPIN-code: 8453-9166S. K. Zyryanov
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
Zyryanov Sergey - MD, professor, Head of Department of General and Clinical Pharmacology.
Moscow
SPIN-code: 2725-9981
References
1. Database of the Population Division of the Department of Economic and Social Affairs of The UN. (In Russ). Режим доступа: https://countrymeters.info/ru/Russian_Federation.
2. Shabanov PD. The contribution of N.P Kravkov in the development of general, developmental, evolutionary and clinical pharmacology (to 150-th anniversary from birthday). Pediatrician. 2015;6(2):114-125. (In Russ).
3. Karasik VM. Problems of age pharmacology — Proceedings of the Jubilee session, Leningrad, 09-11 September 1945. Medgiz. 1947:166-174. (In Russ).
4. Karasik VM. Age-related pharmacology — Pharmacology manual, CH. VIII. Moscow: Medgiz, 1961. (In Russ).
5. Markova IV. Modern problems of age pharmacology. Pharmacology and toxicology. 1981;44(4):494-499. (In Russ).
6. Markova IV, Gusel VA. Pediatrician’s Handbook of clinical pharmacology — LPMI — L.: Medicine. Leningr. otd., 1989. (In Russ).
7. Markova IV, Salyaev VN, Uteshev BS. Pharmacology. Textbook. Moscow: Medicine. 1979. (In Russ).
8. Markova IV, Nezhentsev IB. Pharmacology: Textbook for pediatrician students. SPb.: SOTIS, 1997. (In Russ).
9. Markova IV, Mikhailov IB. Modern medicines: reference book of pediatrician. — M., SPb.: AST Sova, 2007. (In Russ).
10. Makarova VG, Yakushin SS, Natal’skaya NYu. Basics of clinical pharmacology and pharmacotherapy in geriatrics. Practical guide. Ryazan: 2004. (In Russ).
11. Petrov VI. Geriatric pharmacology. Bulletin of the Volgograd State Medical University. 2011;37(1):3-7. (In Russ).
12. Konev YuV, Lazebnik LB. Pharmacotherapy in geriatric practice. Pharmateca. 2016;323(10):26-34. (In Russ).
13. Leonova MV, Alimova EE. Clinical pharmacology in geriatrics. Clinical gerontology. 2018;24(7-8):32-39. (In Russ).
14. Lepakhin VK, Belousov YB., Moiseev VS. Clinical pharmacology with the international nomenclature of medicine. Moscow: 1988. (In Russ).
15. Verlan NV. Experience in implementation of drug safety monitoring system in gerontology. Guidelines. Irkutsk: 2016. (In Russ).
16. Abdulkadyrov KM, et al. Geriatrics. A guide for physicians: Approved UMS of the «SPbGPMU” 25.04.2018, Moscow, 2019. (In Russ).
17. Titova AR, Pasternak EYu, Aseckaya IL, et al. About the safety of antibacterial drugs used in Pediatrics. Safety and risk of pharmacotherapy. 2015;2:12-22. (In Russ).
18. Kutekhova GV, Zhuravleva EA, Darmostukova MA, et al. Signaling messages in pediatric patients. Safety and risk of pharmacotherapy. 2018;6(4):180-186. (In Russ).
19. Syubaev RD, Engalycheva GN, Verstakova OL, et al. Expert criteria for preclinical safety assessment of drug therapy in elderly patients. Statements of the Scientific center of expertise of medical applications. 2012;3:40-43. (In Russ).
Review
For citations:
Romanov B.K., Zyryanov S.K. Pharmacology in special populations: extreme age. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(2):70-74. (In Russ.) https://doi.org/10.24411/2588-0519-2019-10074
Views:
886
Email this article 